Price data is not available
Clinuvel Pharmaceuticals Ltd ADR rose 3.5% from $7.10 to $7.35, behind the S&P 500's +12.3%. Its worst day was Apr 2 (−9.4%), and its low came Jun 10 at $6.19.
Nov 13, 2025 – Jul 17, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Clinuvel Pharmaceuticals Ltd ADR closed at its highest level of the year, 23.2% above where the year started.
+3.6% · S&P 500 +0.5%
Clinuvel Pharmaceuticals Ltd ADR shares fell 8.4%, while the S&P 500 fell 0.9%.
Story events cover the past 12 months · Times ET
−8.4% · S&P 500 −0.9%
Clinuvel Pharmaceuticals Ltd ADR shares rose 10.5%, while the S&P 500 rose 2.9%.
+10.5% · S&P 500 +2.9%
Clinuvel Pharmaceuticals Ltd ADR closed at its lowest level of the year, 12.8% below where the year started.
−7.6% · S&P 500 −1.6%
Where it ended: a close of $7.35 on Jul 17, 2026.
Nothing in the past 12 months.
All CLVLY earningsNothing in the past 12 months.
All CLVLY analyst actionsNothing in the past 12 months.
All CLVLY dividend historyNothing in the past 12 months.
All CLVLY news
